Opisthorchis viverrini
Opisthorchis viverrini is a parasitic fluke that is endemic in Southeast Asia. It is one of the major causes of cholangiocarcinoma, a type of cancer that affects the bile ducts.
Life Cycle[edit]
The life cycle of Opisthorchis viverrini involves three hosts. The adult fluke resides in the bile ducts of the definitive host, which can be a human or a cat. The fluke produces eggs that are excreted in the feces of the host. These eggs are ingested by a snail, the first intermediate host. Inside the snail, the eggs hatch into larvae, which then develop into a stage called cercariae. The cercariae leave the snail and infect a fish, the second intermediate host. Inside the fish, the cercariae develop into metacercariae. When the fish is eaten raw or undercooked by a human or a cat, the metacercariae excyst in the duodenum and ascend the bile duct to mature into adult flukes.
Epidemiology[edit]
Opisthorchis viverrini is endemic in Southeast Asia, particularly in Thailand, Laos, Cambodia, and Vietnam. It is estimated that about 10 million people are infected with this fluke. The main risk factor for infection is the consumption of raw or undercooked fish.
Pathology[edit]
The adult flukes cause inflammation and fibrosis of the bile ducts, leading to cholangitis and cholecystitis. Chronic infection can lead to cholangiocarcinoma, a type of cancer that affects the bile ducts.
Prevention and Control[edit]
Prevention and control of Opisthorchis viverrini infection involve health education, improved sanitation, and control of the intermediate hosts. Treatment with the antihelminthic drug praziquantel is effective in eliminating the adult flukes.
See Also[edit]
-
Opisthorchis viverrini
-
Opisthorchis viverrini
-
Opisthorchis viverrini egg
-
Opisthorchis Life Cycle
-
Chi River
-
Thai fisherman
-
Koi pla
Sponsored Health Resource

W8MD Weight Loss, Sleep & MedSpa
Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.
GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.
- Medical weight loss NYC
- Affordable GLP-1 injections NYC
- Budget GLP-1 weight loss shots Philadelphia
- New Jersey medical weight loss
- NYC medical weight loss blog
- Philadelphia weight loss blog
- Sleep medicine and sleep apnea services
- W8MD MedSpa and wellness
Book a W8MD appointment · View GLP-1 specials
Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
